Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2012, Article ID 607851, 8 pages
http://dx.doi.org/10.1155/2012/607851
Clinical Study

Sorafenib Prevents Escape from Host Immunity in Liver Cirrhosis Patients with Advanced Hepatocellular Carcinoma

Division of Gastroenterology and Hepatology, Toho University Medical Center, Omori Hospital, 6-11-1, Omorinishi, Ota-ku, Tokyo 143-8541, Japan

Received 26 December 2011; Revised 9 March 2012; Accepted 9 March 2012

Academic Editor: Julie R. Ostberg

Copyright © 2012 Hidenari Nagai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [18 citations]

The following is the list of published articles that have cited the current article.

  • C. Tanchot, M. Terme, H. Pere, T. Tran, N. Benhamouda, M. Strioga, C. Banissi, L. Galluzzi, G. Kroemer, and E. Tartour, “Tumor-Infiltrating Regulatory T Cells: Phenotype, Role, Mechanism of Expansion In Situ and Clinical Significance,” Cancer Microenvironment, vol. 6, no. 2, pp. 147–157, 2012. View at Publisher · View at Google Scholar
  • Magali Terme, Orianne Colussi, Elie Marcheteau, Corinne Tanchot, Eric Tartour, and Julien Taieb, “Modulation of Immunity by Antiangiogenic Molecules in Cancer,” Clinical and Developmental Immunology, vol. 2012, pp. 1–8, 2012. View at Publisher · View at Google Scholar
  • Mei-Ling Chen, Bo-Shiun Yan, Wan-Chih Lu, Mei-Huei Chen, Sung-Liang Yu, Pan-Chyr Yang, and Ann-Lii Cheng, “Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity,” International Journal of Cancer, 2013. View at Publisher · View at Google Scholar
  • Minoru Kobayashi, Taro Kubo, Kenji Komatsu, Akira Fujisaki, Fumihito Terauchi, Shinsuke Natsui, Akinori Nukui, Shinsuke Kurokawa, and Tatsuo Morita, “Changes in peripheral blood immune cells: Their prognostic significance in metastatic renal cell carcinoma patients treated with molecular targeted therapy,” Medical Oncology, vol. 30, no. 2, 2013. View at Publisher · View at Google Scholar
  • Bruno Sangro, Carlos Gomez-Martin, Manuel de la Mata, Mercedes Iñarrairaegui, Elena Garralda, Pilar Barrera, Jose Ignacio Riezu-Boj, Esther Larrea, Carlos Alfaro, Pablo Sarobe, Juan José Lasarte, Jose L. Pérez-Gracia, Ignacio Melero, and Jesús Prieto, “A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C,” Journal of Hepatology, 2013. View at Publisher · View at Google Scholar
  • Austin G. Duffy, and Firouzeh Korangy, “Hepatocellular Carcinoma from an Immunologic Perspective,” Clinical Cancer Research, vol. 19, no. 24, pp. 6678–6685, 2013. View at Publisher · View at Google Scholar
  • Hidenari Nagai, Takenori Kanekawa, Kojiro Kobayashi, Takanori Mukozu, Daigo Matsui, Teppei Matsui, Masahiro Kanayama, Noritaka Wakui, Kouichi Momiyama, Mie Shinohara, Koji Ishii, Yoshinori Igarashi, and Yasukiyo Sumino, “Changes of cytokines in patients with liver cirrhosis and advanced hepatocellular carcinoma treated by sorafenib,” Cancer Chemotherapy and Pharmacology, 2013. View at Publisher · View at Google Scholar
  • Yasunari Hiramine, Hirohito Tsubouchi, Tsutomu Tamai, Yasushi Imamura, Yoshirou Baba, Takuya Hiwaki, Hiroka Yamashita, Yukihiko Sho, Kenji Tahara, and Ichiro Kanetsuki, “Efficacy and optimal treatment sequence of Sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma,” Acta Hepatologica Japonica, vol. 54, no. 4, pp. 233–248, 2013. View at Publisher · View at Google Scholar
  • Jeong Won Jang, “Hepatitis B virus reactivation in patients with hepatocellular carcinoma undergoing anti-cancer therapy,” World Journal of Gastroenterology, vol. 20, no. 24, pp. 7675–7685, 2014. View at Publisher · View at Google Scholar
  • Paul Monk, Elaine Lam, Amir Mortazavi, Kari Kendra, Gregory B. Lesinski, Thomas A. Mace, Susan Geyer, William E. Carson, Sanaa Tahiri, Arvinder Bhinder, Steven K. Clinton, and Thomas Olencki, “A Phase I Study of High-Dose Interleukin-2 With Sorafenib in Patients With Metastatic Renal Cell Carcinoma and Melanoma,” Journal of Immunotherapy, vol. 37, no. 3, pp. 180–186, 2014. View at Publisher · View at Google Scholar
  • Thibault Voron, Elie Marcheteau, Simon Pernot, Orianne Colussi, Eric Tartour, Julien Taieb, and Magali Terme, “Control of the Immune Response by Pro-Angiogenic Factors,” Frontiers in Oncology, vol. 4, 2014. View at Publisher · View at Google Scholar
  • Anne-Sophie Chretien, Aude Le Roy, Norbert Vey, Thomas Prebet, Didier Blaise, Cyril Fauriat, and Daniel Olive, “Cancer-Induced Alterations of NK-Mediated Target Recognition: Current and Investigational Pharmacological Strategies Aiming at Restoring NK-Mediated Anti-Tumor Activity,” Frontiers in Immunology, vol. 5, 2014. View at Publisher · View at Google Scholar
  • Thomas C Wirth, “Spontaneous and therapeutic immune responses in hepatocellular carcinoma: implications for current and future immunotherapies,” Expert Review of Gastroenterology & Hepatology, vol. 8, no. 1, pp. 101–110, 2014. View at Publisher · View at Google Scholar
  • Song Liu, Ran-Ran Meng, and Yue-Wei Zhang, “TACE combined with dendritic cells for the treatment of hepatic cancers: Its influence on patient's immune function,” Journal of Interventional Radiology (China), vol. 23, no. 2, pp. 181–184, 2014. View at Publisher · View at Google Scholar
  • A. Lapeyre-Prost, M. Terme, S. Pernot, A.-L. Pointet, T. Voron, E. Tartour, and J. Taieb, “Immunomodulatory Activity of VEGF in Cancer,” 2016. View at Publisher · View at Google Scholar
  • Vikrant Rai, Joe Abdo, Abdullah N. Alsuwaidan, Swati Agrawal, Poonam Sharma, and Devendra K. Agrawal, “Cellular and molecular targets for the immunotherapy of hepatocellular carcinoma,” Molecular and Cellular Biochemistry, 2017. View at Publisher · View at Google Scholar
  • C. Maherzi, F. Onodi, E. Tartour, M. Terme, and C. Tanchot, “Strategies to Reduce Intratumoral Regulatory T Cells,” Oncoimmunology, pp. 483–506, 2017. View at Publisher · View at Google Scholar
  • Hor-Yue Tan, Ning Wang, Wing Lam, Wei Guo, Yibin Feng, and Yung-Chi Cheng, “Targeting tumour microenvironment by tyrosine kinase inhibitor,” Molecular Cancer, vol. 17, no. 1, 2018. View at Publisher · View at Google Scholar